Agios Pharmaceuticals, Inc. issued a press release outlining its anticipated 2024 milestones and value-driving catalysts through 2026, to be discussed at the 42nd Annual J.P. Morgan Healthcare Conference.
AI Assistant
AGIOS PHARMACEUTICALS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.